A study of the circulating fibroblast growth factor 21 as a novel noninvasive biomarker of hepatic injury in genotype-4 chronic hepatitis C: Egyptian patients and their response to...

por El Sagheer, Ghada M, Ahmad, Asmaa K, Abd-ElFattah, Aliaa S, Saad, Zienab M, Hamdi, Lamia
Publicado 2018